Anticipated $1.24 EPS for Medtronic plc (MDT) as of February, 19

Medtronic plc (NYSE:MDT) Corporate Logo
During 2018 Q3 the big money sentiment increased to 1.07. That’s change of 0.09, from 2018Q2’s 0.98. 24 investors sold all, 440 reduced holdings as Medtronic plc ratio is positive. 355 grew stakes while 140 funds bought stakes. Funds hold 1.02 billion shares thus 0.96% less from 2018Q2’s 1.03 billion shares.
Sumitomo Life stated it has 51,501 shs or 0.61% of all its holdings. Cullinan Assocs invested in 0.66% or 93,084 shs. Bb&T Secs Ltd Llc owns 403,566 shs or 0.39% of their US capital. New York-based Trustco National Bank Corp N Y has invested 1.71% in Medtronic plc (NYSE:MDT). Somerset Tru reported 2.61% in Medtronic plc (NYSE:MDT). Nuance Invests Limited Liability Co reported 0.84% stake. Mariner Ltd Liability Corp invested in 124,498 shs. State Of Tennessee Treasury Department accumulated 1.32 million shs. Vigilant Capital Mgmt Ltd Liability Com, Maine-based fund reported 3,128 shs. Toronto Dominion State Bank accumulated 896,769 shs or 0.16% of the stock. Lee Danner And Bass Inc has 59,736 shs. Blb&B Advsrs Ltd Llc reported 6,897 shs. Weatherstone Capital Mgmt reported 2,157 shs. Moreover, Estabrook Capital Mngmt has 0% invested in Medtronic plc (NYSE:MDT) for 153,271 shs. Adams Diversified Equity Fund holds 253,000 shs.

On February, 19 WallStreet anticipated Medtronic plc (NYSE:MDT)’s earnings release, as reported by RTT. Analysts forecast $1.24 earnings per share, which is $0.07 up or 5.98 % from 2018’s $1.17 earnings per share. MDT’s profit could be $1.67B with 18.28 P/E in case $1.24 earnings per share is announced. Wall Street now sees 1.64 % EPS growth despite Medtronic plc last quarter’s EPS of $1.22. The stock increased 0.47% or $0.42 during the last trading session, reaching $90.67.Currently Medtronic plc is uptrending after 18.51% change in last February 14, 2018. MDT has 3.48 million shares volume. MDT outperformed the S&P 500 by 18.51%.

Medtronic plc (NYSE:MDT) Ratings Coverage

Total analysts of 13 have positions in Medtronic (NYSE:MDT) as follows: 9 rated it a “Buy”, 0 with “Sell” and 4 with “Hold”. The positive are 69%. Since August 22, 2018 according to StockzIntelligence Inc Medtronic has 17 analyst reports. On Wednesday, August 22 the stock of Medtronic plc (NYSE:MDT) has “Market Perform” rating given by Wells Fargo. On Wednesday, December 19 the stock of Medtronic plc (NYSE:MDT) has “Overweight” rating given by JP Morgan. On Wednesday, January 2 the firm has “Equal-Weight” rating by Morgan Stanley given. The company rating was maintained by Raymond James on Wednesday, November 21. On Tuesday, January 8 the stock of Medtronic plc (NYSE:MDT) earned “Overweight” rating by Barclays Capital. The company rating was upgraded by BTIG Research on Tuesday, January 15. On Wednesday, August 22 BMO Capital Markets maintained Medtronic plc (NYSE:MDT) rating. BMO Capital Markets has “Outperform” rating and $104 target. On Wednesday, January 2 the company was downgraded by Citigroup. The company rating was maintained by Citigroup on Friday, August 24. The company rating was maintained by Argus Research on Monday, August 27.

Medtronic plc manufactures and sells device medical therapies to hospitals, physicians, clinicians, and patients worldwide.The firm is valued at $121.77 billion. The company's Cardiac and Vascular Group segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; diagnostics and monitoring devices; mechanical circulatory support, TYRX, and AF products; and remote monitoring and patient-centered software.56.88 is the P/E ratio. It also provides transcatheter heart valves, percutaneous coronary intervention stents, surgical valve replacement and repair products, endovascular stent grafts, peripheral vascular products, and products to treat superficial and deep venous diseases.

For more Medtronic plc (NYSE:MDT) news released briefly go to: Investorplace.com, Benzinga.com, Finance.Yahoo.com, Seekingalpha.com or Seekingalpha.com. The titles are as follows: “10 ‘Buy-and-Hold’ Stocks to Own Forever – Investorplace.com” released on February 13, 2019, “BTIG Says Buy The Dip In Medtronic (NYSE:MDT) – Benzinga” on January 15, 2019, “Jim Cramer Advises His Viewers On Brink’s, Medtronic And More – Yahoo Finance” with a publish date: January 18, 2019, “FDA OKs expanded use for Medtronic’s Pipeline Flex embolization device – Seeking Alpha” and the last “Medtronic up 1% premarket on superDimension data – Seeking Alpha” with publication date: January 30, 2019.

Medtronic plc (NYSE:MDT) Analyst Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.